used in combination with intravenous 5-fluorouracil–based chemotherapy, is indicated for first-line treatment of patients with metastatic carcinoma of the colon or rectum.
Related categories 1
Official pharmaceutical website with information for patients and health professionals.
MedlinePlus: Bevacizumab (Injection)
Data provided by NLM, the National Institutes of Health (NIH), government agencies and health-related organizations. Provides information on usage, precautions, side effects and brand names when available.
Last update:January 2, 2007 at 16:33:15 UTC